Mar 20 |
Amicus Therapeutics Issues 2024 Environmental, Social, and Governance (ESG) Report
|
Mar 13 |
13 Best Biotech Stocks To Buy Under $20
|
Mar 7 |
Director Margaret Mcglynn Sells 15,000 Shares of Amicus Therapeutics Inc (FOLD)
|
Mar 5 |
Amicus Therapeutics Stock Sees RS Rating Improve To 74
|
Mar 2 |
Amicus Therapeutics, Inc. (NASDAQ:FOLD) Just Reported Annual Earnings: Have Analysts Changed Their Mind On The Stock?
|
Mar 1 |
Amicus Therapeutics Full Year 2023 Earnings: EPS Misses Expectations
|
Mar 1 |
Amicus Therapeutics to Present at Upcoming Investor Conferences in March 2024
|
Feb 29 |
Amicus Therapeutics, Inc. (NASDAQ:FOLD) Q4 2023 Earnings Call Transcript
|
Feb 29 |
Amicus' (FOLD) Q4 Earnings Beat, Revenues Meet Estimates
|
Feb 29 |
Amicus Therapeutics: Expect Improved Commercial Momentum In 2024
|